{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:22:33Z","timestamp":1777029753729,"version":"3.51.4"},"reference-count":41,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T00:00:00Z","timestamp":1558915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Background: A rise in adrenal incidentalomas (AIs) detection has been observed recently. Even though AIs are detected in asymptomatic patients, thorough assessment may reveal hormonal and metabolic abnormalities or malignant character. Methods: Medical records of 2005 patients (1301 women, 704 men) with 2498 tumors aged 61 \u00b1 11.3 (18\u201393) years, who had been hospitalized due to AI diagnosis, were reviewed. Patients underwent clinical examination, adrenal CT and hormonal assessment. In patients subjected to adrenalectomy, histopathological character of AI was confirmed. Results: AIs most frequently occurred in patients in their 7th decade of life. Hypertension was present in 76.6%, glucose metabolism disorders in 41.3%, and hypercholesterolemia in 60.1% of patients. Lipid-rich adenomas (83.2%) and hormonally inactive tumors (83.1%) predominated. Autonomous cortisol secretion was present or suspected in 6.6%, pheochromocytoma in 4.7%, hyperandrogenism in 3.1%, and primary hyperaldosteronism in 2.4% of patients. The risk of malignancy increased in patients with tumors &gt;6 cm was 37.7%. The logistic regression analysis revealed that the strongest predictor of hormonal activity of AIs was lipid-poor picture on CT scan (OR 7.072; CI 5.118\u20139.771), while the most important factor increasing the risk of malignancy was lipid-poor adenoma or non-adenoma on CT scan (OR 4.843; CI 1.697\u201313.819). Final histopathology was available for 214 tumors; 106 adrenocortical adenomas, 46 pheochromocytomas, and 18 adrenocortical carcinomas were diagnosed. Conclusion: Most AIs are hormonally inactive adenomas. The most frequent hormonal manifestation of AI is subclinical hypercortisolemia. Presence of AI is often accompanied by features of metabolic syndrome. The tumor density on CT scan picture may be predictive of both hormonal activity and the risk of malignancy. Tumors of all sizes may exhibit hormonal activity, while the risk of malignancy significantly increases with the size above 6 cm.<\/jats:p>","DOI":"10.3390\/ijerph16101872","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T11:19:27Z","timestamp":1558955967000},"page":"1872","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Malignancy Risk and Hormonal Activity of Adrenal Incidentalomas in a Large Cohort of Patients from a Single Tertiary Reference Center"],"prefix":"10.3390","volume":"16","author":[{"given":"Ewa","family":"Cyranska-Chyrek","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Szczepanek-Parulska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Olejarz","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-7220","authenticated-orcid":false,"given":"Marek","family":"Ruchala","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,27]]},"reference":[{"key":"ref_1","first-page":"866","article-title":"Management of the adrenal \u201cincidentaloma\u201d","volume":"92","author":"Geelhoed","year":"1982","journal-title":"Surgery"},{"key":"ref_2","first-page":"1530","article-title":"A-I-D-S: The new endocrine epidemic","volume":"79","author":"Griffing","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","first-page":"360","article-title":"Diagnostic pitfalls of adrenal incidentaloma","volume":"68","author":"Grzymislawska","year":"2017","journal-title":"Endokrynol. Pol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.beem.2011.12.006","article-title":"Adrenal incidentaloma","volume":"26","author":"Arnaldi","year":"2012","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000185478","article-title":"Adrenal incidentaloma: An overview of hormonal data from the National Italian Study Group","volume":"47","author":"Mantero","year":"1997","journal-title":"Horm. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5603\/EP.a2016.0039","article-title":"Adrenal incidentaloma in adults-management recommendations by the Polish Society of Endocrinology","volume":"67","author":"Bednarczuk","year":"2016","journal-title":"Endokrynol. Pol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2796.2010.02291.x","article-title":"Adrenal incidentalomas and cardiometabolic morbidity: An emerging association with serious clinical implications","volume":"268","author":"Peppa","year":"2010","journal-title":"J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: Update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: A 15-year retrospective study","volume":"2","author":"Vicennati","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3803\/EnM.2014.29.4.457","article-title":"Clinical Characteristics and Metabolic Features of Patients with Adrenal Incidentalomas with or without Subclinical Cushing\u2019s Syndrome","volume":"29","author":"Kim","year":"2014","journal-title":"Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","article-title":"Patients with subclinical Cushing\u2019s syndrome due to adrenal adenoma have increased cardiovascular risk","volume":"87","author":"Tauchmanova","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/cen.13822","article-title":"Nonfunctioning adrenal incidentaloma: A novel predictive factor for metabolic syndrome","volume":"89","author":"Arruda","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1148\/rg.24si045506","article-title":"Pheochromocytoma: An imaging chameleon","volume":"24","author":"Blake","year":"2004","journal-title":"Radiographics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2214\/ajr.181.6.1811663","article-title":"Low-density pheochromocytoma on CT: A mimicker of adrenal adenoma","volume":"181","author":"Blake","year":"2003","journal-title":"Am. J. Roentgenol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/EJE-09-0384","article-title":"Frequent incidental discovery of phaeochromocytoma: Data from a German cohort of 201 phaeochromocytoma","volume":"161","author":"Kopetschke","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00015458.2010.11680587","article-title":"Phaeochromocytoma: State-of-the-art","volume":"110","author":"Donckier","year":"2010","journal-title":"Acta Chir. Belg."},{"key":"ref_20","first-page":"55","article-title":"Incidentally discovered adrenal tumors: Endocrine and scintigraphic correlates","volume":"83","author":"Barzon","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0889-8529(05)70119-5","article-title":"Management approaches to adrenal incidentalomas. A view from Ancona, Italy","volume":"29","author":"Mantero","year":"2000","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","article-title":"Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia","volume":"20","author":"Williams","year":"2006","journal-title":"J. Hum. Hypertens."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/eje.0.1460523","article-title":"Primary aldosteronism in normokalemic patients with adrenal incidentalomas","volume":"146","author":"Bernini","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J. Hypertens."},{"key":"ref_26","first-page":"17","article-title":"Normokalemic hyperaldosteronism in patients with resistant hypertension","volume":"4","author":"Benchetrit","year":"2002","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00268-008-9513-0","article-title":"Retroperitoneoscopic adrenalectomy in Conn\u2019s syndrome caused by adrenal adenomas or nodular hyperplasia","volume":"32","author":"Walz","year":"2008","journal-title":"World J. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiology.184.3.1509049","article-title":"Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: Reliability of CT","volume":"184","author":"Doppman","year":"1992","journal-title":"Radiology"},{"key":"ref_29","first-page":"299","article-title":"Primary hyperaldosteronism and adrenal incidentaloma: An argument for physiologic testing before adrenalectomy","volume":"41","author":"McAlister","year":"1998","journal-title":"Can. J. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-001-0047-y","article-title":"Adrenocortical carcinomas: Surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group","volume":"25","author":"Icard","year":"2001","journal-title":"World J. Surg."},{"key":"ref_31","first-page":"1014","article-title":"Incidentally discovered adrenal tumors: An institutional perspective","volume":"110","author":"Herrera","year":"1991","journal-title":"Surgery"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2796.2002.01028.x","article-title":"Swedish Research Council Study Group of Endocrine Abdominal Tumours. Adrenal incidentaloma\u2014Experience of a standardized diagnostic programme in the Swedish prospective study","volume":"252","year":"2002","journal-title":"J. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma: Clinical and laboratory observations","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S1.1","article-title":"American Association of Clinical Endocrinologists; American Association of Endocrine Surgeons. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jamcollsurg.2005.11.005","article-title":"Risk assessment in 457 adrenal cortical carcinomas: How much does tumor size predict the likelihood of malignancy?","volume":"202","author":"Sturgeon","year":"2006","journal-title":"J. Am. Coll. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1046\/j.1365-2168.2002.02215.x","article-title":"Adrenal incidentalomas","volume":"89","author":"Duh","year":"2002","journal-title":"Br. J. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00001622-200301000-00013","article-title":"Adrenal incidentaloma","volume":"15","author":"Thompson","year":"2003","journal-title":"Curr. Opin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00268-001-0030-7","article-title":"Adrenal cortical carcinoma","volume":"25","author":"Dackiw","year":"2001","journal-title":"World J. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archsurg.1997.01430320116020","article-title":"Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994","volume":"132","author":"Terzolo","year":"1997","journal-title":"Arch. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00000658-198401000-00021","article-title":"The incidentally discovered adrenal mass","volume":"199","author":"Copeland","year":"1984","journal-title":"Ann. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.surg.2014.06.042","article-title":"A new risk stratification algorithm for the management of patients with adrenal incidentalomas","volume":"156","author":"Birsen","year":"2014","journal-title":"Surgery"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/16\/10\/1872\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:55:30Z","timestamp":1760187330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/16\/10\/1872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,27]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["ijerph16101872"],"URL":"https:\/\/doi.org\/10.3390\/ijerph16101872","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,27]]}}}